rs587776700
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_000256.3(MYBPC3):c.906-1G>C variant causes a splice acceptor, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000154 in 649,866 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000256.3 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYBPC3 | NM_000256.3 | c.906-1G>C | splice_acceptor_variant, intron_variant | ENST00000545968.6 | NP_000247.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYBPC3 | ENST00000545968.6 | c.906-1G>C | splice_acceptor_variant, intron_variant | 5 | NM_000256.3 | ENSP00000442795.1 | ||||
MYBPC3 | ENST00000399249.6 | c.906-383G>C | intron_variant | 5 | ENSP00000382193.2 | |||||
MYBPC3 | ENST00000544791.1 | n.906-1G>C | splice_acceptor_variant, intron_variant | 5 | ENSP00000444259.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000433 AC: 1AN: 230988Hom.: 0 AF XY: 0.00000788 AC XY: 1AN XY: 126936
GnomAD4 exome AF: 0.00000154 AC: 1AN: 649866Hom.: 0 Cov.: 7 AF XY: 0.00000283 AC XY: 1AN XY: 352904
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Cardiomyopathy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario | Apr 29, 2022 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 01, 2022 | Not observed at significant frequency in large population cohorts (gnomAD); Canonical splice site variant predicted to result in a null allele in a gene for which loss of function is a known mechanism of disease; Published functional study demonstrates a damaging effect by activation of a cryptic splice site and produces a frameshift and eventual protein truncation in exon 12 (Frank-Hansen et al., 2008); This variant is associated with the following publications: (PMID: 19574547, 29493010, 29998127, 24704860, 28771489, 18337725) - |
Hypertrophic cardiomyopathy 4 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Sep 01, 2008 | - - |
Hypertrophic cardiomyopathy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 02, 2023 | This sequence change affects an acceptor splice site in intron 9 of the MYBPC3 gene. RNA analysis indicates that disruption of this splice site induces altered splicing and may result in an absent or disrupted protein product. This variant is present in population databases (rs587776700, gnomAD 0.0009%). Disruption of this splice site has been observed in individuals with hypertrophic cardiomyoapthy and/or hypertrophic cardiomyopathy (PMID: 18337725; Invitae). ClinVar contains an entry for this variant (Variation ID: 8619). Studies have shown that disruption of this splice site results in activates a cryptic splice site resulting in a 34 nt intron inclusion. and introduces a premature termination codon (PMID: 18337725). The resulting mRNA is expected to undergo nonsense-mediated decay. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at